Igc Pharma
(NYSEMKT) IGC
Igc Pharma Financials at a Glance
Market Cap
$28.23M
Revenue (TTM)
$1.19M
Net Income (TTM)
$6.55M
EPS (TTM)
$-0.06
P/E Ratio
-4.56
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$0.28
Volume
6,095
Open
$0.29
Price
$0.28
Volume
6,095
Open
$0.29
Previous Close
$0.28
Daily Range
$0.28 - $0.29
52-Week Range
$0.24 - $0.50
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$0.28
Volume
6,095
Open
$0.29
Previous Close
$0.28
Daily Range
$0.28 - $0.29
52-Week Range
$0.24 - $0.50
IGC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Igc Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
70
CEO
Ram Mukunda
Website
www.igcpharma.comHeadquarters
Potomac, MD 20854, US
IGC Financials
Key Financial Metrics (TTM)
Gross Margin
30%
Operating Margin
-9%
Net Income Margin
-6%
Return on Equity
-91%
Return on Capital
-2%
Return on Assets
-71%
Earnings Yield
-21.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$28.23M
Shares Outstanding
100.09M
Volume
6.09K
Avg. Volume
1.09M
Financials (TTM)
Gross Profit
$619.00K
Operating Income
$7.45M
EBITDA
$6.98M
Operating Cash Flow
$4.79M
Capital Expenditure
$482.00K
Free Cash Flow
$5.28M
Cash & ST Invst.
$207.00K
Total Debt
$0.00
Igc Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$317.00K
-3.9%
Gross Profit
$55.00K
-64.3%
Gross Margin
17.35%
N/A
Market Cap
$28.23M
N/A
Market Cap/Employee
$421.28K
N/A
Employees
67
N/A
Net Income
$2.40M
-100.7%
EBITDA
$2.46M
-95.4%
Quarterly Fundamentals
Net Cash
$207.00K
+24.0%
Accounts Receivable
$37.00K
-51.9%
Inventory
$638.00K
-53.1%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-71.29%
N/A
Return on Invested Capital
-1.62%
N/A
Free Cash Flow
$1.22M
-36.6%
Operating Cash Flow
$1.22M
-67.5%